Exercise: A potential contributing factor to the relationship between folate and dementia

Journal of the American Geriatrics Society

Volumn 55, Issue 7, 2007, Pages 1095-1098

  Middleton, Laura E ^a   Kirkland, Susan A ^a   Maxwell, Colleen J ^b   Hogan, David B ^b   Rockwood, Kenneth ^a,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Centre for Health Care of the Elderly   (Canada)

Author keywords

Cerebrovascular outcomes; Dementia; Exercise; Folate; Physical activity

Indexed keywords

FOLIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CANADA; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; EXERCISE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CANADA; COGNITION; DEMENTIA; EXERCISE; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MOTOR ACTIVITY; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL RATE;

EID: 34347381309     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01238.x     Document Type: Article

References (24)

1. Quadri P, Fragiacomo C, Pezzati R et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004 80 : 114 122.
2. Ravaglia G, Forti P, Martelli M et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005 83 : 636 643.
3. Wang HX, Wahlin A, Basun H et al. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 2001 56 : 1188 1194.
4. Stott DJ, MacIntosh G, Lowe GD et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 2005 82 : 1320 1326.
5. Maxwell CJ, Hogan DB, Ebly EM. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord 2002 13 : 225 234.
6. Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006 354 : 1567 1577.
7. Konig D, Bisse E, Deibert P et al. Influence of training volume and acute physical exercise on the homocysteine levels in endurance-training men: Interactions with plasma folate and vitamin B12. Ann Nutr Metab 2003 47 : 114 118.
8. Herrmann M, Schorr H, Obeid R et al. Homocysteine increases during endurance exercise. Clin Chem Lab Med 2003 41 : 1518 1524.
9. Laurin D, Verreault R, Lindsay J et al. Physical Activity and Risk of Cognitive Impairment and Dementia in Elderly Persons. Arch Neurol 2001 38 : 498 504.
10. Ruvio S, Kareholt I, Helkala E et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005 4 : 705 711.
11. Weuve J, Kang JH, Manson JE et al. Physical Activity, including walking, and cognitive function in older women. JAMA 2004 292 : 1454 1461.
12. Wannamethee SG, Shaper AG. Physical activity and the prevention of stroke. J Cardiovasc Risk 1999 6 : 213 216.
13. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987 48 : 314 318.
14. Graham JE, Rockwood K, Beattie BL et al. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology 1996 15 : 246 256.
15. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol 1995 52 : 612 619.
16. Ebly EM, Schaefer JP, Campbell NR et al. Folate status, vascular disease and cognition in elderly Canadians. Age Ageing 1998 27 : 485 491.
17. Davis HS, MacPherson K, Merry HR et al. Reliability and validity of questions about exercise in the Canadian Study of Health and Aging. Int Psychogeriatr 2001 13 : 177 182.
18. Rockwood K, Wentzel C, Hachinski V et al. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000 54 : 447 451.
19. Song X, Mitnitski A, Rockwood K. Index variables for studying outcomes in vascular cognitive impairment. Neuroepidemiology 2005 25 : 196 204.
20. British Committee for Standards in Haematology. Guidelines on the investigation and diagnosis of cobalamin and folate deficiencies. A publication of the British Committee for Standards in Haematology. BCSH General Haematology Test Force. Clin Lab Haematol 1994 16 : 101 115.
21. Galloway M, Rushworth L. Red cell or serum folate? Results from the National Pathology Alliance benchmarking review. J Clin Pathol 2003 56 : 924 926.
22. Stampfer MJ, Grodstein F. Can homocysteine be related to physical functioning? Am J Med 2002 113 : 610 611.
23. Balk EM, Raman G, Tatsioni A et al. Vitamin B6, B12, and folic acid supplementation and cognitive function: A systematic review of randomized trials. Arch Intern Med 2007 167 : 21 30.
24. Stewart R, Asonganyi B, Sherwood R. Plasma homocysteine and cognitive impairment in an older British African-Caribbean population. J Am Geriatr Soc 2002 50 : 1227 1232.